Nifty
Sensex
:
:
13133.90
44632.65
20.15 (0.15%)
14.61 (0.03%)

Pharmaceuticals & Drugs - API

Rating :
63/99

BSE: 506235 | NSE: ALEMBICLTD

105.30
03-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  103.90
  •  107.50
  •  103.25
  •  103.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  913701
  •  966.74
  •  122.80
  •  24.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,701.34
  • 7.33
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,642.49
  • 0.57%
  • 1.42

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.41%
  • 0.72%
  • 20.72%
  • FII
  • DII
  • Others
  • 1.84%
  • 3.90%
  • 2.41%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -9.59
  • -10.33
  • -16.13

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.78
  • -12.15
  • -22.29

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 30.35
  • 30.58

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.41
  • 6.41
  • 6.51

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.37
  • 1.30
  • 1.21

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.24
  • 28.15
  • 26.87

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
16.76
23.65
-29.13%
13.39
26.03
-48.56%
11.48
25.32
-54.66%
12.76
24.31
-47.51%
Expenses
14.28
20.99
-31.97%
12.65
24.62
-48.62%
12.14
21.98
-44.77%
12.88
21.24
-39.36%
EBITDA
2.48
2.66
-6.77%
0.74
1.41
-47.52%
-0.66
3.34
-
-0.12
3.07
-
EBIDTM
14.74%
11.25%
5.53%
5.42%
14.01%
14.01%
-0.94%
12.67%
Other Income
2.68
32.58
-91.77%
2.82
1.48
90.54%
57.28
2.34
2,347.86%
2.06
1.58
30.38%
Interest
0.08
0.06
33.33%
0.09
0.07
28.57%
0.09
0.06
50.00%
0.07
0.05
40.00%
Depreciation
0.97
0.71
36.62%
0.93
0.69
34.78%
0.90
0.71
26.76%
0.93
0.71
30.99%
PBT
4.10
34.47
-88.11%
2.54
2.13
19.25%
55.63
4.91
1,032.99%
0.94
3.90
-75.90%
Tax
0.89
-0.68
-
0.43
0.64
-32.81%
0.16
0.93
-82.80%
0.01
0.67
-98.51%
PAT
3.21
35.15
-90.87%
2.11
1.49
41.61%
55.47
3.98
1,293.72%
0.93
3.23
-71.21%
PATM
19.15%
148.63%
15.76%
5.72%
7.11%
7.11%
7.29%
13.29%
EPS
0.13
1.37
-90.51%
0.08
0.06
33.33%
2.16
0.15
1,340.00%
0.04
0.13
-69.23%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Net Sales
54.39
73.93
123.81
125.30
147.16
127.53
143.95
1,138.14
1,116.07
994.44
Net Sales Growth
-45.23%
-40.29%
-1.19%
-14.85%
15.39%
-11.41%
-87.35%
1.98%
12.23%
 
Cost Of Goods Sold
4,654.64
12.17
66.95
78.50
96.33
69.67
74.09
572.04
559.08
484.02
Gross Profit
-4,600.25
61.75
56.86
46.79
50.83
57.86
69.86
566.10
556.99
510.43
GP Margin
-8,457.90%
83.52%
45.93%
37.34%
34.54%
45.37%
48.53%
49.74%
49.91%
51.33%
Total Expenditure
51.95
70.79
106.46
114.22
140.45
121.53
135.35
1,024.55
1,031.58
848.36
Power & Fuel Cost
-
0.91
2.34
1.11
5.46
13.26
13.30
33.98
38.08
28.05
% Of Sales
-
1.23%
1.89%
0.89%
3.71%
10.40%
9.24%
2.99%
3.41%
2.82%
Employee Cost
-
20.79
20.52
19.64
22.83
23.79
27.00
145.47
131.69
97.62
% Of Sales
-
28.12%
16.57%
15.67%
15.51%
18.65%
18.76%
12.78%
11.80%
9.82%
Manufacturing Exp.
-
25.52
7.11
6.08
7.11
5.77
11.90
91.62
96.22
90.89
% Of Sales
-
34.52%
5.74%
4.85%
4.83%
4.52%
8.27%
8.05%
8.62%
9.14%
General & Admin Exp.
-
8.30
7.15
6.80
6.48
5.30
4.66
76.82
68.22
53.45
% Of Sales
-
11.23%
5.77%
5.43%
4.40%
4.16%
3.24%
6.75%
6.11%
5.37%
Selling & Distn. Exp.
-
0.87
0.11
0.34
0.90
2.11
2.88
92.16
87.12
79.71
% Of Sales
-
1.18%
0.09%
0.27%
0.61%
1.65%
2.00%
8.10%
7.81%
8.02%
Miscellaneous Exp.
-
2.23
2.28
1.75
1.33
1.64
1.51
12.45
51.18
14.63
% Of Sales
-
3.02%
1.84%
1.40%
0.90%
1.29%
1.05%
1.09%
4.59%
1.47%
EBITDA
2.44
3.14
17.35
11.08
6.71
6.00
8.60
113.59
84.49
146.08
EBITDA Margin
4.49%
4.25%
14.01%
8.84%
4.56%
4.70%
5.97%
9.98%
7.57%
14.69%
Other Income
64.84
93.54
30.17
37.04
30.97
28.81
21.73
11.22
15.01
34.85
Interest
0.33
0.29
0.22
0.17
0.16
0.12
0.83
37.98
52.06
34.56
Depreciation
3.73
3.23
2.63
3.78
5.09
6.14
6.04
43.02
38.31
32.77
PBT
63.21
93.17
44.67
44.18
32.44
28.55
23.46
43.81
9.13
113.60
Tax
1.49
0.13
3.59
2.39
-0.86
0.61
-0.69
4.27
-1.69
1.95
Tax Rate
2.36%
0.14%
8.04%
5.41%
-3.23%
2.41%
-2.94%
9.75%
-18.51%
1.72%
PAT
61.72
93.03
41.08
41.78
27.49
24.72
24.15
39.54
10.82
111.65
PAT before Minority Interest
61.72
93.03
41.08
41.78
27.49
24.72
24.15
39.54
10.82
111.65
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
113.48%
125.84%
33.18%
33.34%
18.68%
19.38%
16.78%
3.47%
0.97%
11.23%
PAT Growth
40.75%
126.46%
-1.68%
51.98%
11.21%
2.36%
-38.92%
265.43%
-90.31%
 
EPS
2.40
3.62
1.60
1.63
1.07
0.96
0.94
1.54
0.42
4.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Shareholder's Funds
1,418.04
1,208.53
1,085.77
911.43
803.13
527.81
337.29
331.01
341.37
Share Capital
51.36
51.36
53.41
53.41
53.41
53.41
26.70
27.44
27.69
Total Reserves
1,366.69
1,157.17
1,032.37
858.02
749.72
474.40
310.58
303.57
313.67
Non-Current Liabilities
6.88
8.52
14.15
12.61
14.69
38.03
422.22
481.85
418.64
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
249.31
215.76
277.55
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
159.06
259.68
145.92
Long Term Provisions
0.70
0.72
0.80
0.78
0.64
1.57
0.00
0.00
0.00
Current Liabilities
45.80
48.80
59.12
68.34
57.68
81.80
269.87
230.03
203.88
Trade Payables
12.99
24.75
16.42
14.76
16.36
19.19
197.79
169.19
136.88
Other Current Liabilities
22.07
8.07
31.82
39.20
27.37
26.22
20.42
18.97
15.31
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
10.74
15.97
10.89
14.38
13.95
36.39
51.66
41.87
51.69
Total Liabilities
1,470.72
1,265.85
1,159.04
992.38
875.50
647.64
1,029.38
1,042.89
963.89
Net Block
130.68
186.88
147.46
147.60
146.42
169.02
393.18
404.78
366.62
Gross Block
145.37
202.45
160.37
158.33
371.75
402.34
712.34
681.78
605.50
Accumulated Depreciation
14.69
15.57
12.92
10.73
225.34
233.33
319.15
277.00
238.88
Non Current Assets
1,307.90
1,167.08
972.32
801.10
706.29
458.23
405.46
420.29
401.28
Capital Work in Progress
3.08
22.26
31.64
0.16
0.00
2.47
3.90
7.16
21.96
Non Current Investment
1,173.28
957.76
792.85
651.28
558.62
286.52
8.37
8.33
12.70
Long Term Loans & Adv.
0.86
0.17
0.38
2.05
1.25
0.23
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
162.82
98.77
186.73
191.28
169.21
189.41
623.91
622.60
562.61
Current Investments
53.71
43.46
119.85
104.76
46.13
12.23
0.00
0.00
1.35
Inventories
35.41
35.33
32.41
50.61
74.90
84.31
244.95
238.39
202.81
Sundry Debtors
8.98
13.51
25.29
21.60
27.98
48.04
192.87
213.00
230.54
Cash & Bank
58.85
2.01
0.84
2.32
2.34
2.64
23.85
16.41
18.66
Other Current Assets
5.86
1.88
2.01
2.10
17.87
42.19
162.25
154.81
109.24
Short Term Loans & Adv.
4.38
2.59
6.34
9.88
16.24
42.19
162.25
154.81
109.24
Net Current Assets
117.03
49.97
127.61
122.94
111.53
107.61
354.04
392.57
358.73
Total Assets
1,470.72
1,265.85
1,159.05
992.38
875.50
647.64
1,029.37
1,042.89
963.89

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
6.17
21.51
23.58
51.63
9.65
149.09
123.09
53.54
PBT
93.17
44.67
44.18
26.63
25.33
43.81
16.65
91.05
Adjustment
-85.70
-20.51
-28.85
-20.86
-16.51
73.14
113.95
59.65
Changes in Working Capital
0.24
1.99
11.89
46.06
1.70
36.16
-4.37
-109.70
Cash after chg. in Working capital
7.70
26.15
27.22
51.83
10.52
153.11
126.23
41.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.53
-4.64
-3.64
-0.20
-0.87
-4.02
-3.13
-3.27
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-6.75
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
56.72
71.67
-22.40
-46.69
-4.76
-23.50
-55.55
-225.13
Net Fixed Assets
76.26
-32.70
-33.47
213.26
344.49
-27.30
-61.48
Net Investments
-86.41
70.53
-63.48
-62.37
-141.47
-0.04
5.60
Others
66.87
33.84
74.55
-197.58
-207.78
3.84
0.33
Cash from Financing Activity
-6.05
-92.01
-2.66
-4.96
-5.19
-118.15
-69.79
38.55
Net Cash Inflow / Outflow
56.85
1.17
-1.48
-0.02
-0.30
7.45
-2.25
-133.05
Opening Cash & Equivalents
2.01
0.84
2.32
2.34
2.64
16.41
18.66
151.71
Closing Cash & Equivalent
58.85
2.01
0.84
2.32
2.34
23.85
16.41
18.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
55.22
47.06
40.66
34.13
30.08
19.77
12.63
12.06
12.33
ROA
6.80%
3.39%
3.88%
2.94%
3.25%
2.88%
3.82%
1.08%
11.58%
ROE
7.08%
3.58%
4.18%
3.21%
3.71%
5.58%
11.83%
3.22%
32.71%
ROCE
7.12%
3.91%
4.44%
3.12%
3.82%
3.82%
10.54%
7.79%
19.37%
Fixed Asset Turnover
0.43
0.69
0.80
0.58
0.35
0.27
1.65
1.76
1.70
Receivable days
55.52
56.38
67.34
59.14
103.47
293.96
64.48
71.40
81.97
Inventory Days
174.64
98.43
119.22
149.70
216.71
401.78
76.79
71.03
72.11
Payable days
120.48
74.61
55.73
40.49
60.75
331.66
68.63
56.58
59.67
Cash Conversion Cycle
109.69
80.19
130.83
168.35
259.43
364.08
72.65
85.84
94.40
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
1.21
1.44
1.24
Interest Cover
324.49
207.64
261.78
169.23
221.26
29.30
2.15
1.18
4.29

Top Investors:

News Update:


  • Alembic reports 91% fall in Q2 consolidated net profit
    4th Nov 2020, 12:08 PM

    Total consolidated income of the company decreased by 65.46% at Rs 19.43 crore for Q2FY21

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.